Procter & Gamble reported adjusted Q3 EPS of $1.59, topping the $1.56 consensus by $0.03.
Revenue reached $21.2 billion, beating the $20.57 billion estimate and reflecting a 7% year‑over‑year increase.
All five segments posted organic growth, led by Beauty at 7% and Fabric & Home Care and Baby care each at 3%.
Shares rose 1.6% post‑release; FY2026 core EPS guidance remains $6.83‑$7.09, with outlook for flat‑to‑4% organic sales growth.